#1 Clinical Trials Search in Europe

Estradiol Hemihydrate

This article examines the use of Estradiol Hemihydrate, a form of estrogen, in several clinical trials. These studies investigate its effectiveness in treating various conditions, including anorexia nervosa, endometrial hyperplasia, menopausal symptoms, and urinary tract issues. The trials explore different administration methods, such as transdermal patches, oral tablets, and vaginal applications, to determine the most effective and safe ways to use this hormone therapy.

Table of Contents

What is Estradiol Hemihydrate?

Estradiol hemihydrate is a form of estrogen, which is a female sex hormone. It is chemically and biologically identical to the estradiol naturally produced in the human body[1]. This medication is classified as a human estrogen and is used in various medical treatments, particularly for women experiencing hormonal changes or deficiencies.

Estradiol hemihydrate is also known by several other names, including:

  • 17β-estradiol
  • Estradiol valerate
  • Femiest
  • Vagifem

These alternative names may be used interchangeably in medical literature and product descriptions[2][1].

Medical Uses

Estradiol hemihydrate is used to treat various conditions related to estrogen deficiency. Some of the primary medical uses include:

  1. Menopausal Symptoms: It helps alleviate symptoms associated with menopause, such as hot flashes, night sweats, and vaginal dryness[3].
  2. Vulvar and Vaginal Atrophy: This condition involves thinning, drying, and inflammation of the vaginal walls due to lower estrogen levels. Estradiol hemihydrate can help treat these symptoms[1].
  3. Osteoporosis Prevention: In postmenopausal women, estradiol can help maintain bone density and reduce the risk of fractures[4].
  4. Hormone Replacement Therapy (HRT): It is used as part of HRT regimens for women who have undergone hysterectomy or are experiencing premature ovarian failure[3].
  5. Fertility Treatment: Estradiol hemihydrate is used in some fertility treatments, particularly in preparing the uterus for embryo transfer in frozen embryo transfer (FET) cycles[5].

Forms and Administration

Estradiol hemihydrate is available in several forms, each with its own method of administration:

  1. Oral Tablets: These are taken by mouth, usually once or multiple times daily[5].
  2. Transdermal Patches: These are applied to the skin and changed periodically, often weekly[4].
  3. Transdermal Gel: This is applied to the skin, typically once daily[5].
  4. Vaginal Tablets: These are inserted into the vagina using an applicator[1].

The dosage and frequency of administration can vary depending on the specific condition being treated and the individual patient’s needs. Always follow your healthcare provider’s instructions carefully.

Effectiveness

Research has shown that estradiol hemihydrate is effective in treating various conditions related to estrogen deficiency. For example:

  • In treating vulvar and vaginal atrophy, vaginal tablets containing 10 mcg of estradiol have been shown to be effective[1].
  • For menopausal symptoms, both oral and transdermal forms of estradiol have demonstrated effectiveness in reducing hot flashes and improving quality of life[3].
  • In fertility treatments, estradiol is used to prepare the endometrium (uterine lining) for embryo implantation, with both oral and transdermal forms showing promising results[5].

Side Effects and Risks

While estradiol hemihydrate can be beneficial for many women, it’s important to be aware of potential side effects and risks:

  • Common side effects may include breast tenderness, nausea, headaches, and mood changes[3].
  • Skin reactions such as rash, itching, or burning may occur with transdermal applications[5].
  • Rare but serious risks can include blood clots, stroke, and certain types of cancer. The risk of these complications may increase with long-term use or in women with certain pre-existing conditions[3].

It’s crucial to discuss all potential risks and benefits with your healthcare provider before starting any estrogen therapy.

Ongoing Research

Researchers continue to study estradiol hemihydrate to better understand its effects and potential uses. Some areas of ongoing research include:

  • Comparing the effectiveness and safety of different administration routes (oral vs. transdermal) for various conditions[5].
  • Investigating the effects of estradiol on bone health in adolescents with anorexia nervosa[4].
  • Studying the impact of estradiol on cardiovascular health in postmenopausal women[3].

These ongoing studies aim to provide more comprehensive information about the optimal use of estradiol hemihydrate in different patient populations and for various medical conditions.

Study Focus Administration Method Key Outcomes Measured Duration
Anorexia Nervosa and Bone Health Transdermal patch Bone density, cortical wall thickness 24 months
Endometrial Hyperplasia Oral Apoptotic signaling pathways 30 days
Menopausal Symptoms and Cardiovascular Health Oral and transdermal Coagulation activation, metabolic risk factors 6 months
Lower Urinary Tract Symptoms in Postmenopausal Women Vaginal Storage symptom improvement, quality of life 3 months

FAQ

  • What is Estradiol Hemihydrate? Estradiol Hemihydrate is a form of estrogen, the primary female sex hormone. It is used in hormone replacement therapy to treat various conditions related to estrogen deficiency, such as menopausal symptoms and certain bone disorders.
  • How is Estradiol Hemihydrate administered in these clinical trials? In the trials discussed, Estradiol Hemihydrate is administered through various methods, including transdermal patches, oral tablets, and vaginal applications. The specific method and dosage depend on the condition being treated and the study design.
  • What conditions are being studied using Estradiol Hemihydrate? The clinical trials are investigating the use of Estradiol Hemihydrate for several conditions, including anorexia nervosa and its effects on bone health, endometrial hyperplasia, menopausal symptoms, cardiovascular health in postmenopausal women, and lower urinary tract symptoms in postmenopausal women.
  • Are there any side effects associated with Estradiol Hemihydrate treatment? While specific side effects vary depending on the administration method and dosage, some potential side effects mentioned in the trials include breast pain, peripheral edema, and postmenopausal bleeding. However, it's important to note that side effects can vary among individuals and should be discussed with a healthcare provider.
  • How long do these clinical trials typically last? The duration of the clinical trials varies. Some studies last for several months, such as the 6-month study comparing oral and transdermal hormone therapy, while others may extend up to 24 months, as seen in the study on anorexia nervosa and bone health.

Ongoing Clinical Trials on Estradiol Hemihydrate

  • Study on Improving Sexual Health and Quality of Life in Cervical Cancer Patients Using Estriol, Estradiol Hemihydrate, and Promestriene

    Recruiting

    1 1 1 1
    Investigated drugs:
    Spain

  • Study on the Effects of Vaginal Estrogen Treatment with Nomegestrol Acetate and Estradiol Hemihydrate on Blood Clotting in Postmenopausal Women with Vaginal Atrophy

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on the Effectiveness of Hormonal Treatment with Estradiol Hemihydrate and Testosterone in Adolescents with Gender Dysphoria

    Recruiting

    1 1 1 1
    Investigated drugs:
    France

  • Study on the Effectiveness of Vaginal Micronized Progesterone for Infertility in Patients Undergoing Assisted Conception with Frozen Embryo Transfer (AC-FET)

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study on Infertility: Effects of Choriogonadotropin Alfa, Nomegestrol Acetate, Estradiol Hemihydrate, and Progesterone in Patients Undergoing Frozen Embryo Transfer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Study Comparing Two Treatment Sequences of CDK4/6 Inhibitors (Abemaciclib, Palbociclib, or Ribociclib) in Hormone Receptor Positive Advanced Breast Cancer

    Not recruiting

    1 1 1 1
    Investigated drugs:
    The Netherlands

Glossary

  • Estradiol Hemihydrate: A form of estrogen used in hormone replacement therapy to treat various conditions related to estrogen deficiency.
  • Transdermal: A method of administering medication through the skin, often in the form of patches or gels.
  • Anorexia Nervosa: An eating disorder characterized by an abnormally low body weight, intense fear of gaining weight, and a distorted perception of body weight.
  • Endometrial Hyperplasia: An overgrowth of the lining of the uterus (endometrium), which can sometimes lead to uterine cancer.
  • Menopausal Symptoms: Physical and emotional symptoms experienced by women during menopause, such as hot flashes, night sweats, and mood changes.
  • Bone Density: A measure of the amount of calcium and other minerals in bones, used to assess bone strength and the risk of fractures.
  • IGF-1: Insulin-like Growth Factor 1, a hormone that plays a crucial role in childhood growth and continues to have anabolic effects in adults.
  • Vasomotor Symptoms: Physical symptoms such as hot flashes and night sweats that are common during menopause.
  • Hormone Replacement Therapy (HRT): The use of hormones, typically estrogen and progesterone, to treat symptoms of menopause and other hormone-related conditions.
  • Lower Urinary Tract Symptoms (LUTS): A group of urinary symptoms that can affect the bladder, urinary sphincter, and urethra, often causing issues with urination.

References

  1. https://clinicaltrials.gov/study/NCT01753102
  2. https://clinicaltrials.gov/study/NCT00829114
  3. https://clinicaltrials.gov/study/NCT00668603
  4. https://clinicaltrials.gov/study/NCT04021017
  5. https://clinicaltrials.gov/study/NCT05802303